Huma offers a health platform used for remote patient monitoring and biological data gathering for preventative healthcare.
Huma has raised $80.0M in total funding. The most recent round was Series D. The last funding was announced in July 2024.
Huma's investors include Hitachi Ventures, Samsung NEXT, AstraZeneca, Sony Innovation Fund, Leaps by Bayer.
Huma is headquartered in London, United Kingdom.
Huma offers a health platform used for remote patient monitoring and biological data gathering for preventative healthcare.
Huma is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Huma — Funding & Investors." VCBacked, July 16, 2024, https://www.vcbacked.co/company/huma. Accessed September 29, 2026.
VCBacked. (2024). Huma — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/huma
{{cite web |title=Huma — Funding & Investors |url=https://www.vcbacked.co/company/huma |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated